A Novel Machine Learning Based Framework for Developing Composite Digital Biomarkers of Disease Progression
Song Zhai, Andy Liaw, Judong Shen, Yuting Xu, Vladimir Svetnik, James J. FitzGerald, Chrystalina A. Antoniades, Dan Holder, Marissa F. Dockendorf, Jie Ren, Richard Baumgartner
doi: https://doi.org/10.1101/2024.09.23.24313737
Song Zhai
1Biostatistics and Research Decision Sciences, Merck & Co., Inc., Rahway, NJ 07065, USA
Andy Liaw
1Biostatistics and Research Decision Sciences, Merck & Co., Inc., Rahway, NJ 07065, USA
Judong Shen
1Biostatistics and Research Decision Sciences, Merck & Co., Inc., Rahway, NJ 07065, USA
Yuting Xu
1Biostatistics and Research Decision Sciences, Merck & Co., Inc., Rahway, NJ 07065, USA
Vladimir Svetnik
1Biostatistics and Research Decision Sciences, Merck & Co., Inc., Rahway, NJ 07065, USA
James J. FitzGerald
3NeuroMetrology Lab, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
4Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom
Chrystalina A. Antoniades
3NeuroMetrology Lab, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
Dan Holder
1Biostatistics and Research Decision Sciences, Merck & Co., Inc., Rahway, NJ 07065, USA
Marissa F. Dockendorf
2Digital Clinical Measures, Translational Medicine, Merck & Co., Inc., Rahway, NJ 07065, USA
Jie Ren
2Digital Clinical Measures, Translational Medicine, Merck & Co., Inc., Rahway, NJ 07065, USA
Richard Baumgartner
1Biostatistics and Research Decision Sciences, Merck & Co., Inc., Rahway, NJ 07065, USA
Data Availability
The original data presented in this paper is from the ongoing OxQUIP study and cannot be shared until completion of the whole study and full dissemination of results. This is expected to become possible within 24 months from the end of the study. Qualified researchers will be able to contact the Principal Investigator at the University of Oxford.
Posted September 24, 2024.
A Novel Machine Learning Based Framework for Developing Composite Digital Biomarkers of Disease Progression
Song Zhai, Andy Liaw, Judong Shen, Yuting Xu, Vladimir Svetnik, James J. FitzGerald, Chrystalina A. Antoniades, Dan Holder, Marissa F. Dockendorf, Jie Ren, Richard Baumgartner
medRxiv 2024.09.23.24313737; doi: https://doi.org/10.1101/2024.09.23.24313737
A Novel Machine Learning Based Framework for Developing Composite Digital Biomarkers of Disease Progression
Song Zhai, Andy Liaw, Judong Shen, Yuting Xu, Vladimir Svetnik, James J. FitzGerald, Chrystalina A. Antoniades, Dan Holder, Marissa F. Dockendorf, Jie Ren, Richard Baumgartner
medRxiv 2024.09.23.24313737; doi: https://doi.org/10.1101/2024.09.23.24313737
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12766)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4600)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (926)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (471)
- Neurology (4377)
- Nursing (237)
- Nutrition (640)
- Oncology (2278)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1533)
- Respiratory Medicine (916)
- Rheumatology (441)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)